These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 237589)

  • 1. Studies on a circulating anticoagulant in systemic lupus erythematosus: evidence for inhibition of the function of activated plasma thromboplastin antecedent (factor XIa).
    Krieger H; Leddy JP; Breckenridge RT
    Blood; 1975 Aug; 46(2):189-97. PubMed ID: 237589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus.
    Yin ET; Gaston LW
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):88-115. PubMed ID: 16955969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating anticoagulants in disseminated lupus erythematosus. Apropos of 3 cases].
    Krulik M; Tobelem G; Audebert AA; Mougeot-Martin M; Debray J
    Ann Med Interne (Paris); 1977 Jan; 128(1):57-62. PubMed ID: 855970
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating anticoagulants.
    Green D
    Med Clin North Am; 1972 Jan; 56(1):145-51. PubMed ID: 4550288
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and properties of the anticoagulant principle of Trimeresurus gramineus venom.
    Ouyang C; Yang FY
    Biochim Biophys Acta; 1975 Apr; 386(2):479-92. PubMed ID: 1138881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique precipitating autoantibody against plasma thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus.
    Poon MC; Saito H; Koopman WJ
    Blood; 1984 Jun; 63(6):1309-17. PubMed ID: 6426550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Hageman factor, plasma thromboplastin antecedent, thrombin and other clotting factors by phenylglyoxal hydrate (38500).
    Radnoff OD; Saito H
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):177-82. PubMed ID: 236567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical study of the lupus anticoagulant.
    Schleider MA; Nachman RL; Jaffe EA; Coleman M
    Blood; 1976 Oct; 48(4):499-509. PubMed ID: 963290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating inhibitors of blood coagulation associated with procainamide-induced lupus erythematosus.
    Davis S; Furie BC; Griffin JH; Furie B; Willey R
    Am J Hematol; 1978; 4(4):401-7. PubMed ID: 717399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus.
    Castro O; Farber LR; Clyne LP
    Ann Intern Med; 1972 Oct; 77(4):543-8. PubMed ID: 4642734
    [No Abstract]   [Full Text] [Related]  

  • 12. THE MODE OF ACTION OF A COAGULATION INHIBITOR IN THE BLOOD OF TWO PATIENTS WITH DISSEMINATED LUPUS ERYTHEMATOSUS (DLE).
    BIGGS R; DENSON KW
    Br J Haematol; 1964 Apr; 10():198-216. PubMed ID: 14141619
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating anticoagulant in disseminated lupus erythematosus. Proposed mode of action.
    Veltkamp JJ; Kerkhoven P; Loeliger EA
    Haemostasis; 1973-1974; 2(6):253-9. PubMed ID: 4137579
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquired factor XI inhibitor in systemic lupus erythematosus--case report and literature review.
    Bortoli R; Monticielo OA; Chakr RM; Palominos PE; Rohsig LM; Kohem CL; Xavier RM; Brenol JC
    Semin Arthritis Rheum; 2009 Aug; 39(1):61-5. PubMed ID: 18519152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of plasma thromboplastin antecedent (factor XI): studies on mechanism of inhibition.
    Goldsmith GH; Silverman P
    J Lab Clin Med; 1985 Sep; 106(3):279-85. PubMed ID: 3875671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant.
    Mannucci PM; Canciani MT; Mari D; Meucci P
    Scand J Haematol; 1979 May; 22(5):423-32. PubMed ID: 472662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic mechanisms in blood coagulation.
    Davie EW; Fujikawa K
    Annu Rev Biochem; 1975; 44():799-829. PubMed ID: 237463
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of split products of fibrinogen on results of blood coagulation tests and platelet adhesiveness.
    Niléhn JE
    Scand J Haematol; 1967 Dec; 4(6):430-40. PubMed ID: 5583024
    [No Abstract]   [Full Text] [Related]  

  • 19. Acquired inhibitors of blood coagulation.
    Feinstein DI; Rapaport SI
    Prog Hemost Thromb; 1972; 1():75-95. PubMed ID: 4569725
    [No Abstract]   [Full Text] [Related]  

  • 20. [Report of two cases of circulating anticoagulant directed against factor xi (author's transl)].
    Vila M; Monasterio J; Arangüena PV; Valentin P; Pico M; Triginer J
    Sangre (Barc); 1978; 23(2):202-9. PubMed ID: 653555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.